National Institute for Health and Care Excellence (2020) Liraglutide for managing overweight and obesity
The analysis found only a modest decrease in stroke risk (13% lower relative risk reduction) and a nonsignificant trend (14% lower relative risk reduction) for heart attack risk
Prescription GLP-1 medications like semaglutide and tirzepatide are commonly used for diabetes and weight loss
Once injected, GLP-1 analogues hit peak blood levels fasterusually within two hours
Focusing on improving side effects associated with glucagon-like peptide-1 agonist (GLP-1) therapies, there is an increased requirement for nutrition support products, hydration solutions, and educational materials
CrossRef Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model Yi-Fan Li, Lan-Qing Yao, Chao Li, Hong Ren, Jin-Bo Gong, Han Wu, Li-Hui Gu, Ying-Jian Liang, Yu-Ze Yang, Kong-Ying Lin, Zi-Qiang Li, Qi-Xuan Zheng, Ting-Hao Chen, Ya-Hao Zhou, Hong Wang, Hong-Wei Guo, Jia-Hao Xu, Zhong Chen, Feng Shen, Ming-Da Wang, Tian Annals of Surgical Oncology .2025
